OSANG HEALTHCARE (오상헬스케어)
Developer and manufacturer of in‑vitro diagnostic (IVD) devices and reagents with R&D and commercial operations across biochemical, immunological and molecular diagnostics. Offers blood glucose monitoring systems, HbA1c and biochemical analyzers, rapid immunoassays and PCR‑based molecular tests, supported by device engineering, cartridge/consumable development, software integration and global distribution to 100+ countries. Reports regulatory clearances including FDA and CE approvals and maintains programs for manufacturing quality, ESG and compliance.
Industries
Health Care
Health Diagnostics
Medical Device
Medical Equipment Manufacturing
Nr. of Employees
medium (51-250)
OSANG HEALTHCARE (오상헬스케어)
Expertise Areas
- In‑vitro diagnostics (biochemistry, immunodiagnostics, molecular diagnostics)
- Blood glucose monitoring and enzymatic biosensor systems
- Real‑time PCR and nucleic acid amplification assay development
- Rapid immunoassay (lateral flow) development
Key Technologies
- Real‑time PCR / nucleic acid amplification
- Enzyme‑based glucose biosensors
- Immunochromatography / lateral flow assays
- Integrated sample‑to‑answer cartridge design